Treatment of Chronic Wounds with Skin Autografting Combined With ReCell&reg;

Treatment of Chronic Wounds with Skin Autografting Combined With ReCell&reg; - Skin autografting combined with ReCell&reg; for chronic wounds

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011966

Enrollment

Registered

2013-10-15

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of chronic wounds is clinically challenging based on low graft take rates associated with traditional surger.

Interventions

patients received a split-thickness autograft combined with ReCell&amp

reg

(experimental group) patients received autograft alone as the control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a chronic wound (defined as a wound that remained unhealed for more than 4 weeks) which required surgical debridement and skin grafting were eligible.

Exclusion criteria

Exclusion criteria: 1. patients considered a high anesthesiology or surgical risk. 2. Patient with severe systemic disease. 3. Patient with concomitant use of corticosteroids. 4. Patient with hypersensitivity to trypsin or Hartmann solution.

Design outcomes

Primary

Measure	Time frame
Effectiveness	—

Secondary

Measure	Time frame
safety	—

Countries

Asia(except Japan)

Contacts

Public ContactBing Tang

The First Affiliated Hospital of Sun Yat-sen University Department of Burn Surgery

zhujiay@mail.sysu.edu.cn+86-20-87755766-8235

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Treatment of Chronic Wounds with Skin Autografting Combined With ReCell&amp;reg;